Oncogenes such as KRAS, PI3K/AKT, and MYC have been shown to enhance NRF2 transcription and stability, creating a feedback loop that favors metabolic reprogramming under conditions that promote tumor proliferation. Here, NFE2L2 is linked to neoplasm.